| 前收市價 | 24.02 |
| 開市 | 24.46 |
| 買盤 | 23.00 x 800 |
| 賣出價 | 24.28 x 800 |
| 今日波幅 | 23.77 - 24.67 |
| 52 週波幅 | 22.52 - 54.30 |
| 成交量 | |
| 平均成交量 | 856,052 |
| 市值 | 1.905B |
| Beta 值 (5 年，每月) | 1.61 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -4.47 |
| 業績公佈日 | 2023年11月06日 - 2023年11月10日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 65.14 |
InvestorPlace7 Best Cathie Wood Stocks for Your May 2023 Buy List
Cathie Wood invests in speculative stocks that don’t always pan out, as 2022 showed. The chief of Ark Investment Management watched her firm outperform in 2021, though last year saw a sharp deceleration in interest in various hough-growth names. Indeed, her firm’s top 10 holdings all lost significant amounts of value. Accordingly, it’s become more and more clear that these Cathie Wood stocks are volatile bets, and should be treated as such. However, after a dismal 2022, these Cathie Wood stocks
InvestorPlaceThe 3 Most Promising Gene Editing Stocks to Buy in 2023
Gene editing stocks are one of the hottest sectors in medicine today. Genes are the foundation of life, and from creating new organisms to curing incurable diseases, the editing of genes can bring radical changes to life as we know it. That’s why CRISPR stocks that can edit genes have been in such demand both in research and in the biochemistry sector. But while gene editing can do many things, it can be hard to sort out science-fact from science-fiction. There are still many challenges that gen
InvestorPlace3 Stocks to Watch in April: Is it Time to Buy?
Heading toward the midway point of the year, the unique dynamics associated with the post-pandemic new normal sets the stage for certain stocks to watch. That is, brewing fundamental and technical factors appear to favor fortuitously structured or positioned enterprises. While it’s a bit risky to be bullish at this juncture, some ideas might be worth your speculation-earmarked funds. Notably, three publicly traded companies seem poised for a big move ahead. To be 100% clear, there’s no guarantee
